Lee, S.H.; Lee, H.S.; Lee, S.H.; Woo, S.M.; Kim, D.U.; Bang, S.
Efficacy and Safety of Pembrolizumab for Gemcitabine/Cisplatin-Refractory Biliary Tract Cancer: A Multicenter Retrospective Study. J. Clin. Med. 2020, 9, 1769.
https://doi.org/10.3390/jcm9061769
AMA Style
Lee SH, Lee HS, Lee SH, Woo SM, Kim DU, Bang S.
Efficacy and Safety of Pembrolizumab for Gemcitabine/Cisplatin-Refractory Biliary Tract Cancer: A Multicenter Retrospective Study. Journal of Clinical Medicine. 2020; 9(6):1769.
https://doi.org/10.3390/jcm9061769
Chicago/Turabian Style
Lee, Sang Hoon, Hee Seung Lee, Sang Hyub Lee, Sang Myung Woo, Dong Uk Kim, and Seungmin Bang.
2020. "Efficacy and Safety of Pembrolizumab for Gemcitabine/Cisplatin-Refractory Biliary Tract Cancer: A Multicenter Retrospective Study" Journal of Clinical Medicine 9, no. 6: 1769.
https://doi.org/10.3390/jcm9061769
APA Style
Lee, S. H., Lee, H. S., Lee, S. H., Woo, S. M., Kim, D. U., & Bang, S.
(2020). Efficacy and Safety of Pembrolizumab for Gemcitabine/Cisplatin-Refractory Biliary Tract Cancer: A Multicenter Retrospective Study. Journal of Clinical Medicine, 9(6), 1769.
https://doi.org/10.3390/jcm9061769